文献速递系统性红斑狼疮

狼疮患者报告结局对系统性红斑狼疮患者损伤累积的预测效度:LUNA注册研究

Predictive validity of Lupus Patient-Reported Outcome for damage accrual in patients with systemic lupus erythematosus: the LUNA Registry.
PubMed 文献 · Rheumatology (Oxford) · 2025-01-01

在日本全国多中心LUNA注册中,1295例系统性红斑狼疮患者数据显示,基线狼疮患者报告结局(Lupus PRO)的健康相关生活质量(HR-QOL)越高,纵向SDI评分增加越少,呈剂量依赖效应;非健康相关生活质量与SDI无显著关联。

要点

  • 基线HR-QOL较高者SDI年均增加-0.005(95%CI -0.007至-0.004,P<0.001)。
  • HR-QOL按三分位分组,第二分位较第一分位SDI年均变化-0.101(95%CI -0.172至-0.030),第三分位-0.211(95%CI -0.281至-0.142)。
  • 认知、生育和身体健康领域HR-QOL与纵向总SDI评分显著相关;非HR-QOL与SDI无显著关联。

核心结论

  • Lupus PRO的HR-QOL较高与SDI评分增加较低相关,提示疾病特异性HR-QOL测量对评估预后具有重要性。

研究设计与样本

  • 日本全国多中心注册(LUNA)研究,纳入1295例有≥2次纵向测量的系统性红斑狼疮患者。
  • 使用Lupus PRO问卷评估健康相关(HR)和非健康相关(非HR)生活质量,以SDI评估损伤累积。
  • 采用混合效应模型分析基线Lupus PRO评分与纵向SDI评分的关联,并校正预后因素。

主要发现

  • 基线HR-QOL较高者SDI年均增加-0.005(95%CI -0.007至-0.004,P<0.001)。
  • HR-QOL按三分位分组呈剂量依赖效应:第二分位较第一分位SDI年均变化-0.101(95%CI -0.172至-0.030),第三分位较第一分位-0.211(95%CI -0.281至-0.142)。
  • 非HR-QOL与SDI评分无显著关联。
  • HR-QOL中认知、生育和身体健康领域与纵向总SDI评分显著相关。
  • HR-QOL与激素依赖性和非激素依赖性SDI评分均相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The predictive validity of disease-specific quality of life (QOL) remains unknown in patients with systemic lupus erythematosus (SLE), although disease-specific measures are equally or more responsive to changes than generic QOL. We aimed to examine the predictive validity of the Lupus Patient-Reported Outcome (PRO) for damage accrual. METHODS: Patients with SLE and ≥2 measurements over time were included in the Japanese nationwide multicentre registry (LUNA). The Lupus PRO questionnaire contains both health-related (HR) and non-HR QOL measures. Damage accrual was evaluated using the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SDI). We examined the association between the Lupus PRO score at baseline and longitudinal SDI scores using mixed-effects models adjusted for prognostic factors. RESULTS: Among 1295 patients, those with higher HR-QOL of Lupus PRO at baseline demonstrated a significantly lower increase in SDI (-0.005/year, 95% confidence interval [CI]: -0.007 to -0.004, P < 0.001). According to the categorization of HR-QOL based on tertile, a similar dose-dependent effect of HR-QOL on longitudinal SDI was identified (second vs first tertile category: -0.101/year, 95% CI: -0.172 to -0.030; third tertile category: -0.211/year, 95% CI: -0.281 to -0.142). Non-HR-QOL was not significantly associated with the SDI scores. Among the HR-QOL domains, cognition, procreation and physical health were significantly associated with the total SDI scores over time. HR-QOL was associated with corticosteroid-dependent and -independent SDI scores. CONCLUSION: A higher HR-QOL of Lupus PRO was associated with a lower increase in SDI scores. Our findings imply the importance of disease-specific HR-QOL measurements in assessing prognosis.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Nose Y, Onishi A, Nishimura K, et al. Predictive validity of Lupus Patient-Reported Outcome for damage accrual in patients with systemic lupus erythematosus: the LUNA Registry. Rheumatology (Oxford). 2025. PMID: 38885408. doi:10.1093/rheumatology/keae341

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。